A thorough study of Clear Cell Renal Cell Carcinoma (ccRCC) shows that combining tyrosine kinase inhibitors (TKI) with immune checkpoint inhibitors (ICI) shows promising results in addressing the tumor-promoting influences of abnormal immunological and molecular biomarkers in metastatic Clear Cell Renal Cell Carcinoma (ccRCC). These abnormal biomarkers enhance drug resistance, support tumor growth, and trigger cancer-related genes. Ongoing clinical trials are testing new treatment options that appear more effective than earlier ones. However, more research is needed to confirm their long-term safety use and potential side effects. This study highlights vital molecular and immunological biomarkers associated with drug resistance in Clear Cell Renal Cell Carcinoma (ccRCC). Furthermore, this study identifies a number of promising drug candidates and biomarkers that serve as significant contributors to the enhancement of the overall survival of ccRCC patients. Consequently, this article offers pertinent insights on both recently completed and ongoing clinical trials, recommending further toxicity study for the prolonged use of this treatment strategy for patients with metastatic ccRCC, while equipping researchers with invaluable information for the progression of current treatment strategies.

Currently, there is no standard treatment for renal cell carcinoma (RCC) that is free of side effects and resistance. Additionally, limited information exists on how curcumin affects the gene expression profiles of patients with translocation renal cell carcinoma (tRCC) and papillary renal cell carcinoma (pRCC). The pathways responsible for metastasis in tRCC are still not well understood, and there is no established treatment or reliable biomarker to predict outcomes for metastatic tRCC. Primary clinical data from patients were retrieved from the TCGA database and analyzed using cBioPortal, stitch, string, R and Python. Various analyses were performed, including differential gene expression, protein-protein interaction (PPI) network analysis, drug-targeted gene analysis, gene ontology (GO), enrichment analyses, and systematic searches to assess the impact of curcumin on the transcriptomic profiles of tRCC, pRCC, and clear cell renal cell carcinoma (ccRCC). No significant impact of sensitive genes on survival in KIRC and KIRP was found, though a trend suggested they may delay disease progression. The combination of curcumin with sunitinib showed promise in overcoming drug resistance in ccRCC by inducing ferroptosis, reducing iron, and increasing ADAMTS18 expression. This study, leveraging data from the TCGA database and other databases explored the impact of curcumin on transcriptomic profiles in tRCC, pRCC, and clear cell RCC (ccRCC). Gene analysis revealed immune and metabolic differences, with KIRC showing a stronger immune response. This study is the first to propose that future research into the miR-148/ADAMTS18 genes and the ferroptosis pathway in tRCC and pRCC could lead to the development of new therapies and the identification of novel therapeutic targets, potentially overcoming drug resistance and metastasis.

The research provides an appraisal of the factors affecting the use of field tripin teaching and learning of Biology in the College of Education Akwanga, Nasarawa State. It provides an analysis of the nature of field tripin teaching and learning biology and its significance. The research not only proffers a methodology of teaching and learning of biology but also elucidate the factors affecting its use. Questionnaires were administered and ninety-one of them returned for analysis. The analysis used was a simple percentage to ascertain the use of field trips in teaching and learning of Biology in the College of Education Akwanga, Nasarawa State. From the findings, it was clearly seen that the use of field trip in teaching and learning biology is very vital as can be shown in the use of field trip in teaching and learning biology is very vital as shown in the summary of the data collected, 827 responses representing 39.55% strongly agreed with the twenty-three questions or statements presented in the questionnaires. 1005 responses representing 48.10% agreed with the twenty-three questions or statements presented in the questionnaires. Only 187 responses representing 8.94% disagreed with the twenty-three questions or statements presented in the questionnaires and 72 responses representing 3.44% strongly disagreed with the twenty-three questions or statements presented in the questionnaires. The percentage of respondents that strongly agreed and agreed was higher than the percentage of respondents that disagreed or strongly disagreed.